![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EWE Jonsson and SE Dahlen
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
The aim of the study was to investigate if antigen-induced contraction of guinea pig lung parenchyma (GPLP) was an appropriate model for the study of antileukotriene drugs. Antileukotrienes have recently shown antiasthmatic effects in humans. Challenge of GPLP with a cumulatively increasing concentration of antigen evoked a graded contractile response. The antigen response could be divided into an immediate peak phase and a plateau phase of long duration. Histamine antagonism alone (mepyramine, H1, and metiamide, H2) had no effect on the response, whereas 5-lipoxygenase (5-lox) inhibitors (BAY x1005, MK-886 or BWA4C) depressed the plateau phase. When 5-lipoxygenase inhibition (BAY x1005 or MK-886) or cysteinyl-leukotriene receptor antagonism (ICI 198,615) was combined with histamine antagonism, there was a major attenuation of both components of the antigen response, leaving only a small residual response. In contrast, cyclooxygenase inhibition (diclofenac or indomethacin), antagonism of platelet-activating factor (WEB 2086) and thromboxane receptor antagonism combined with inhibition of thromboxane synthesis (BAY u3405 and CS-518) failed to inhibit the antigen response. In conclusion, cysteinyl-leukotrienes and histamine synergistically mediated the major part of the Schultz-Dale response in GPLP. The characteristics of GPLP anaphylaxis closely resembled those of antigen-challenged human bronci, supporting that antigen challenge of GPLP is a suitable model in experimental asthma research.
This article has been cited by other articles:
|
|
 |
|
  A. R. Ressmeyer, A. K. Larsson, E. Vollmer, S. E. Dahlen, S. Uhlig, and C. Martin Characterisation of guinea pig precision-cut lung slices: comparison with human tissues Eur. Respir. J., September 1, 2006; 28(3): 603 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-K. Larsson, M. Back, J. Hjoberg, and S.-E. Dahlen Inhibition of Nitric-Oxide Synthase Enhances Antigen-Induced Contractions and Increases Release of Cysteinyl-Leukotrienes in Guinea Pig Lung Parenchyma: Nitric Oxide as a Protective Factor J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sundstrom, L. Lastbom, A. Ryrfeldt, and S.-E. Dahlen Interactions among Three Classes of Mediators Explain Antigen-Induced Bronchoconstriction in the Isolated Perfused and Ventilated Guinea Pig Lung J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 408 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. TSANG and W. S. FRED WONG Inhibitors of Tyrosine Kinase Signaling Cascade Attenuated Antigen Challenge of Guinea-Pig Airways In Vitro Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 126 - 133. [Abstract] [Full Text]
|
|
|
|
|
|
W. S. F. Wong, D. S. K. Koh, A. H. M. Koh, W. L. Ting, and P. T. H. Wong Effects of Tyrosine Kinase Inhibitors on Antigen Challenge of Guinea Pig Lung In Vitro J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 131 - 137. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
